Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Korro Bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 71 | 2 | 84 | +15 |
| Shares | 8.54M | 110.0K | 9.45M | +1.02M (+12.1%) |
| Value | $285.3M | $3.68M | $359.6M | +$78.0M (+27.7%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Korro Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (9)
Institutions that held Korro Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Cormorant Asset Management, LP | 265,826 | $8.88M |
| ExodusPoint Capital Management, LP | 41,257 | $1.38M |
| Hudson Bay Capital Management LP | 30,000 | $1.00M |
| Vestcor Inc | 3,000 | $100.0K |
| Brown Brothers Harriman & Co | 2,854 | $95.4K |
| Jaffetilchin Investment Partners, LLC | 945 | $31.6K |
| Quarry LP | 600 | $20.1K |
| TD Waterhouse Canada Inc. | 29 | $957 |
| City State Bank | 20 | $668 |
Not filed for Q4 2024 yet (2)
Institutions that held Korro Bio, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ghost Tree Capital, LLC | 110,000 | $3.68M |
| Carmichael Hill & Associates, Inc. | 5 | $168 |